Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kobayashi Pharmaceutical Co Ltd (KBYPF)
OTHER OTC:KBYPF
RESEARCH TOOLSreports
Holding KBYPF?
Track your performance easily
KBYPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$31.11 - $48.51
Previous Close$34.61
Volume3.00
Average Volume (3M)N/A
Market Cap
$2.58B
Enterprise Value$1.91B
Total Cash (Recent Filing)¥104.53B
Total Debt (Recent Filing)¥792.00M
Price to Earnings (P/E)37.8
Beta0.42
Next Earnings
Jan 31, 2025EPS Estimate
$0.51Next Dividend Ex-Date
Dec 27, 2024Dividend Yield1.85%
Share Statistics
EPS (TTM)0.92
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.07
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$36.37Price Target Upside11.96% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Kobayashi Pharmaceutical Co News
PremiumCompany Announcements
Kobayashi Pharmaceutical Reports Challenging Third Quarter
PremiumPre-Earnings
Is KBYPF a Buy, Before Earnings?Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.73% Mutual Funds
― Other Institutional Investors
92.89% Public Companies and
Individual Investors
KBYPF FAQ
What was Kobayashi Pharmaceutical Co Ltd’s price range in the past 12 months?
Kobayashi Pharmaceutical Co Ltd lowest stock price was $31.11 and its highest was $48.51 in the past 12 months.
What is Kobayashi Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Kobayashi Pharmaceutical Co Ltd’s upcoming earnings report date?
Kobayashi Pharmaceutical Co Ltd’s upcoming earnings report date is Jan 31, 2025 which is in 79 days.
How were Kobayashi Pharmaceutical Co Ltd’s earnings last quarter?
Kobayashi Pharmaceutical Co Ltd released its earnings results on Nov 08, 2024. The company reported $0.341 earnings per share for the quarter, missing the consensus estimate of $0.535 by -$0.193.
Is Kobayashi Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Kobayashi Pharmaceutical Co Ltd’s price is currently Undervalued.
Does Kobayashi Pharmaceutical Co Ltd pay dividends?
Kobayashi Pharmaceutical Co Ltd pays a Annually dividend of $0.38 which represents an annual dividend yield of 1.85%. See more information on Kobayashi Pharmaceutical Co Ltd dividends here
What is Kobayashi Pharmaceutical Co Ltd’s EPS estimate?
Kobayashi Pharmaceutical Co Ltd’s EPS estimate is $0.51.
How many shares outstanding does Kobayashi Pharmaceutical Co Ltd have?
Kobayashi Pharmaceutical Co Ltd has 78,050,000 shares outstanding.
What happened to Kobayashi Pharmaceutical Co Ltd’s price movement after its last earnings report?
Kobayashi Pharmaceutical Co Ltd reported an EPS of $0.341 in its last earnings report, missing expectations of $0.535. Following the earnings report the stock price went down -0.028%.
Which hedge fund is a major shareholder of Kobayashi Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in KBYPF
---
Kobayashi Pharmaceutical Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$36.37 (11.96% Upside)
$36.37 (11.96% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.76%
12-Months-Change
Fundamentals
Return on Equity
4.77%
Trailing 12-Months
Asset Growth
-3.55%
Trailing 12-Months
Company Description
Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers and skincare. The company's unique strategy of creating and cultivating adjacencies has resulted in over 30% market share in its major categories. Kobayashi mainly sells its products in drugstores, convenience stores and general merchandise stores, or GMSes. It generates around 85% of its sales from Japan, and is expanding overseas business in the U.S., China, and southeast Asia.
---
KBYPF Stock 12 Month Forecast
Average Price Target
$36.37
▲(11.96% Upside)
Technical Analysis
Takeda Pharmaceutical Company
―
Daiichi Sankyo Company
―
Otsuka Holdings Co
―
Aurinia Pharmaceuticals
―
Best Analysts Covering KBYPF
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+5.20%
reiterated a sell rating 9 days ago
Copying Hisae Kawamoto's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.20% per trade.
---